Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers

BACKGROUND: Prostate cancer (PCa) management can benefit from novel concepts/biomarkers for reducing the current 20-30% chance of false-negative diagnosis with standard histopathology of biopsied tissue. METHOD: We explored the potential of selected epigenetic markers in combination with validated h...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanovski, Darko, Tang, George, Wawrowsky, Kolja, Boston, Raymond C., Lambrecht, Nils, Tajbakhsh, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593641/
https://www.ncbi.nlm.nih.gov/pubmed/28915670
http://dx.doi.org/10.18632/oncotarget.18985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593641/
https://www.ncbi.nlm.nih.gov/pubmed/28915670
http://dx.doi.org/10.18632/oncotarget.18985

Ejemplares similares